共 50 条
- [1] SCHEDULE DEPENDENCY OF ANTILEUKEMIC ACTIVITY OF PODOPHYLLOTOXIN-DERIVATIVE VP 16-213 (NSC-141540) IN L1210 LEUKEMIA ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION A-PATHOLOGY, 1973, A 81 (05): : 715 - 724
- [3] COMBINATION CHEMOTHERAPY WITH AMSA ON L1210 LEUKEMIA AND B-16 MELANOMA EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1981, 17 (09): : 1017 - 1021
- [6] VP 16-213 AND CYTOSINE-ARABINOSIDE COMBINATION CHEMOTHERAPY FOR REFRACTORY ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (12): : 1471 - 1475
- [7] ETOPOSIDE (VP 16-213 - VEPESID) MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1984, 26 (661): : 48 - 49
- [8] MONO AND COMBINATION CHEMOTHERAPY WITH VP 16-213 IN SMALL CELL LUNG-CANCER (SLC) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 308 - 308
- [9] KINETICS OF CYTOTOXICITY OF VM-26 AND VP-16-213 ON L1210 LEUKEMIA AND HEMATOPOIETIC STEM-CELLS CANCER TREATMENT REPORTS, 1978, 62 (09): : 1313 - 1320